Literature DB >> 5839882

Determination of the hepatic blood flow in man by simultaneous use of five test substances measured in two parts of the liver.

K Winkler, J A Larsen, T Munkner, N Tygstrup.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5839882

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN： 0036-5513            Impact factor:   1.713


× No keyword cloud information.
  9 in total

1.  Portal and systemic haemodynamic response to acute and chronic administration of low and high dose isosorbide-5-mononitrate in patients with cirrhosis.

Authors:  A L Jones; I H Bangash; J Walker; K J Simpson; N D Finlayson; P C Hayes
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

2.  Portal and systemic haemodynamic action of N-acetylcysteine in patients with stable cirrhosis.

Authors:  A L Jones; I H Bangash; I A Bouchier; P C Hayes
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

3.  Hemodynamic patterns in human hepatic cirrhosis: a prospective randomized study of the hemodynamic sequelae of distal splenorenal (Warren) and mesocaval shunts.

Authors:  F A Reichle; O E Owen
Journal:  Ann Surg       Date:  1979-10       Impact factor: 12.969

4.  Glycerol clearance in alcoholic liver disease.

Authors:  D G Johnston; K G Alberti; R Wright; P G Blain
Journal:  Gut       Date:  1982-04       Impact factor: 23.059

5.  Pharmacokinetics of biliary excretion in man. VI. Indocyanine green.

Authors:  D K Meijer; B Weert; G A Vermeer
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  A measurement of regional portal blood flow with Xe-133 and balloon catheter in man.

Authors:  Y Yasuhara; S Miyauchi; K Hamamoto
Journal:  Eur J Nucl Med       Date:  1989

7.  Evaluation of aggregated IgG in mice as an Fc receptor specific probe of the hepatic mononuclear phagocyte system.

Authors:  R A Jimenez; M Mannik
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

8.  A phase 2 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP).

Authors:  Fiona J Gifford; Philip D J Dunne; Graeme Weir; Hamish Ireland; Catriona Graham; Sharon Tuck; Peter C Hayes; Jonathan A Fallowfield
Journal:  Trials       Date:  2020-03-12       Impact factor: 2.279

9.  The hepatic vasculature and its response to hepatic injury: a working hypothesis.

Authors:  D S Zimmon
Journal:  Yale J Biol Med       Date:  1977 Sep-Oct
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.